TY - JOUR
T1 - Clinical Features of Patients With Second Primary Lung Cancer After Head and Neck Cancer
AU - Takatsu, Fumiaki
AU - Suzawa, Ken
AU - Okazaki, Mikio
AU - Shien, Kazuhiko
AU - Yamamoto, Hiromasa
AU - Watanabe, Mototsugu
AU - Hayama, Makio
AU - Ueno, Tsuyoshi
AU - Sugimoto, Ryujiro
AU - Maki, Yuho
AU - Fujiwara, Toshiya
AU - Okita, Riki
AU - Inokawa, Hidetoshi
AU - Tao, Hiroyuki
AU - Hirami, Yuji
AU - Matsuda, Eisuke
AU - Kataoka, Kazuhiko
AU - Yamashita, Motohiro
AU - Sano, Yoshifumi
AU - Matsuura, Motoki
AU - Mizutani, Hisao
AU - Toyooka, Shinichi
N1 - Funding Information:
The authors wish to thank Dr Toshiharu Mitsuhashi (Center for Innovative Clinical Medicine, Okayama University, Okayama, Japan) for his advice on statistics. The authors have no funding sources to disclose. The authors have no conflicts of interest to disclose.
Publisher Copyright:
© 2022 The Society of Thoracic Surgeons
PY - 2022
Y1 - 2022
N2 - Background: In survivors of head and neck cancer (HNC), second primary lung cancer (SPLC) often develop as a result of a common risk factor, that is, smoking. A multicenter experience was reviewed to evaluate how the history of a diagnosis of HNC affects the outcomes of patients undergoing pulmonary resection for SPLC. Methods: A multicenter retrospective analysis of patients hospitalized between January 2012 and December 2018 was performed. From a cohort of 4521 patients undergoing therapeutic pulmonary resection for primary non-small cell lung cancer, 100 patients with a previous history of HNC (HNC group) were identified. These patients were compared with a control group consisting of 200 patients without an HNC history from the same cohort pair-matched with operating facility, age, sex, and pathologic stage of lung cancer. Results: At the time of surgery for SPLC, the HNC group showed malnutrition with a lower prognostic nutritional index compared with the control group (P < .001). The HNC group was determined to have postoperative complications more frequently (P = .02). The 5-year overall survival rates in the HNC and control groups were 59.0% and 83.2%, respectively (P < .001). Statistically, HNC history, lower prognostic nutritional index, squamous cell lung cancer, and TNM stage were identified to be independently associated with poor survival. Conclusions: Patients with SPLC after primary HNC often present with malnutrition and are predisposed to postoperative complications and poor survival after pulmonary resection.
AB - Background: In survivors of head and neck cancer (HNC), second primary lung cancer (SPLC) often develop as a result of a common risk factor, that is, smoking. A multicenter experience was reviewed to evaluate how the history of a diagnosis of HNC affects the outcomes of patients undergoing pulmonary resection for SPLC. Methods: A multicenter retrospective analysis of patients hospitalized between January 2012 and December 2018 was performed. From a cohort of 4521 patients undergoing therapeutic pulmonary resection for primary non-small cell lung cancer, 100 patients with a previous history of HNC (HNC group) were identified. These patients were compared with a control group consisting of 200 patients without an HNC history from the same cohort pair-matched with operating facility, age, sex, and pathologic stage of lung cancer. Results: At the time of surgery for SPLC, the HNC group showed malnutrition with a lower prognostic nutritional index compared with the control group (P < .001). The HNC group was determined to have postoperative complications more frequently (P = .02). The 5-year overall survival rates in the HNC and control groups were 59.0% and 83.2%, respectively (P < .001). Statistically, HNC history, lower prognostic nutritional index, squamous cell lung cancer, and TNM stage were identified to be independently associated with poor survival. Conclusions: Patients with SPLC after primary HNC often present with malnutrition and are predisposed to postoperative complications and poor survival after pulmonary resection.
UR - http://www.scopus.com/inward/record.url?scp=85131570057&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131570057&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2022.04.052
DO - 10.1016/j.athoracsur.2022.04.052
M3 - Article
C2 - 35595090
AN - SCOPUS:85131570057
SN - 0003-4975
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
ER -